These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9179205)

  • 1. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
    Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
    Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
    Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
    Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
    Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
    Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast masses.
    Adalet I; Demirkol MO; Müslümanoğlu M; Bozfakioğlu Y; Cantez S
    Nucl Med Commun; 1997 Feb; 18(2):118-21. PubMed ID: 9076766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technetium-99m-tetrofosmin radionuclide mammography in the diagnosis of malignant breast tumors].
    Jauković L
    Vojnosanit Pregl; 2004; 61(1):35-40. PubMed ID: 15022387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
    Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
    Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
    Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
    Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintimammography using Tc-99m tetrofosmin.
    Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
    Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
    Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
    Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
    Lee JK; Kao CH; Sun SS
    Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
    Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
    J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions.
    Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H
    Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
    Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
    Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.
    Tschabitscher D; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Molnar M; Dinges HP; Kroiss A; Lind P
    J Nucl Med; 1997 Nov; 38(11):1786-7. PubMed ID: 9374356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.
    Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS
    Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.